Core Viewpoint - The company Baiotai has signed a licensing and commercialization agreement with SteinCares for the exclusive rights to commercialize BAT2406 injection in Brazil and other Latin American markets, with a total agreement value of up to $10 million [1] Group 1 - The agreement includes an upfront payment of $1 million and milestone payments not exceeding $9 million [1] - Baiotai will receive a revenue share based on a double-digit percentage of net sales as per the agreement [1] - The agreement is effective upon signing and has an initial term of fifteen years [1] Group 2 - The signing of this agreement is expected to have a positive impact on the company's future performance [1]